PACB vs. OSCR
PACB (Pacific Biosciences of California, Inc.) and OSCR (Oscar Health, Inc.) are both stocks. Both are in the Healthcare sector — PACB in Diagnostics & Research, OSCR in Healthcare Plans. Over the past 5 years, PACB returned -46.26%/yr vs 2.29%/yr for OSCR. At a 0.34 correlation, their price movements are largely independent.
Performance
PACB vs. OSCR - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PACB achieves a -29.95% return, which is significantly lower than OSCR's 96.66% return.
PACB
- 1D
- -2.96%
- 1M
- 8.26%
- YTD
- -29.95%
- 6M
- -38.21%
- 1Y
- 9.17%
- 3Y*
- -54.65%
- 5Y*
- -46.26%
- 10Y*
- -17.53%
OSCR
- 1D
- -2.25%
- 1M
- 21.18%
- YTD
- 96.66%
- 6M
- 69.93%
- 1Y
- 102.58%
- 3Y*
- 43.22%
- 5Y*
- 2.29%
- 10Y*
- —
PACB vs. OSCR - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
PACB Pacific Biosciences of California, Inc. | -29.95% | 2.19% | -81.35% | 19.93% | -60.02% | -40.42% |
OSCR Oscar Health, Inc. | 96.66% | 6.92% | 46.89% | 271.95% | -68.66% | -78.19% |
Correlation
The correlation between PACB and OSCR is 0.22, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.22 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.23 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.33 |
Correlation (All Time) Calculated using the full available price history since Mar 3, 2021 | 0.34 |
The correlation between PACB and OSCR shifts across timeframes, from 0.22 (1 year) to 0.34 (all time), reflecting how their relationship changes across market environments.
Fundamentals
PACB:
$400.62M
OSCR:
$9.32B
PACB:
-$0.43
OSCR:
-$0.14
PACB:
2.47
OSCR:
0.61
PACB:
3.82
OSCR:
5.60
PACB:
$160.03M
OSCR:
$13.30B
PACB:
$59.34M
OSCR:
$895.79M
PACB:
-$146.34M
OSCR:
$19.23M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PACB vs. OSCR — Risk / Return Rank
PACB
OSCR
PACB vs. OSCR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Pacific Biosciences of California, Inc. (PACB) and Oscar Health, Inc. (OSCR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| PACB | OSCR | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.12 | ||
| Sortino ratioReturn per unit of downside risk | -1.14 | ||
| Omega ratioGain probability vs. loss probability | 1.09 | 1.25 | -0.15 |
| Calmar ratioReturn relative to maximum drawdown | 0.19 | 1.89 | -1.70 |
| Martin ratioReturn relative to average drawdown | 0.36 | 3.51 | -3.15 |
Loading charts...
Drawdowns
PACB vs. OSCR - Drawdown Comparison
The maximum PACB drawdown since its inception was -98.22%, roughly equal to the maximum OSCR drawdown of -94.15%. Use the drawdown chart below to compare losses from any high point for PACB and OSCR.
Loading charts...
Drawdown Indicators
| PACB | OSCR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.22% | -94.15% | -4.07% |
Max Drawdown (1Y)Largest decline over 1 year | -58.05% | -51.71% | -6.34% |
Max Drawdown (3Y)Largest decline over 3 years | -93.47% | -53.39% | -40.08% |
Max Drawdown (5Y)Largest decline over 5 years | -97.47% | -91.21% | -6.26% |
Max Drawdown (10Y)Largest decline over 10 years | -98.22% | — | — |
Current DrawdownCurrent decline from peak | -97.44% | -23.14% | -74.30% |
Average DrawdownAverage peak-to-trough decline | -70.53% | -64.96% | -5.57% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 30.69% | 27.78% | +2.91% |
Volatility
PACB vs. OSCR - Volatility Comparison
Pacific Biosciences of California, Inc. (PACB) and Oscar Health, Inc. (OSCR) have volatilities of 23.75% and 24.83%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PACB | OSCR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 23.75% | 24.83% | -1.08% |
Volatility (6M)Calculated over the trailing 6-month period | 56.74% | 44.97% | +11.77% |
Volatility (1Y)Calculated over the trailing 1-year period | 88.70% | 78.24% | +10.46% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 94.39% | 80.60% | +13.79% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 84.71% | 79.96% | +4.75% |
Dividends
PACB vs. OSCR - Dividend Comparison
Neither PACB nor OSCR has paid dividends to shareholders.
Financials
PACB vs. OSCR - Financials Comparison
This section allows you to compare key financial metrics between Pacific Biosciences of California, Inc. and Oscar Health, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
PACB and OSCR have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
OSCR has higher volatility (24.83%) compared to PACB (23.75%). In terms of maximum drawdown, PACB dropped -98.22% vs OSCR's -94.15%.
OSCR currently has the higher Sharpe Ratio (1.25 vs 0.12), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PACB and OSCR
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer